| Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1267-1288, 2018 | 664 | 2018 |
| Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis W Van Rheenen, A Shatunov, AM Dekker, RL McLaughlin, FP Diekstra, ... Nature genetics 48 (9), 1043-1048, 2016 | 642 | 2016 |
| Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72 A Chiò, G Borghero, G Restagno, G Mora, C Drepper, BJ Traynor, ... Brain 135 (3), 784-793, 2012 | 244 | 2012 |
| Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial JS Mora, A Genge, A Chio, CJ Estol, D Chaverri, M Hernández, S Marín, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21 (1-2), 5-14, 2020 | 223 | 2020 |
| Burden, depression, and anxiety in caregivers of people with amyotrophic lateral sclerosis F Pagnini, G Rossi, C Lunetta, P Banfi, G Castelnuovo, M Corbo, ... Psychology, Health & Medicine 15 (6), 685-693, 2010 | 192 | 2010 |
| Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis S Bandres‐Ciga, AJ Noyce, G Hemani, A Nicolas, A Calvo, G Mora, ... Annals of neurology 85 (4), 470-481, 2019 | 180 | 2019 |
| Polymeric biomaterials for 3D printing in medicine: An overview R Pugliese, B Beltrami, S Regondi, C Lunetta Annals of 3D Printed Medicine 2, 100011, 2021 | 178 | 2021 |
| Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells G Nardo, S Pozzi, M Pignataro, E Lauranzano, G Spano, S Garbelli, ... PloS one 6 (10), e25545, 2011 | 168 | 2011 |
| Genetic counselling in ALS: facts, uncertainties and clinical suggestions A Chiò, S Battistini, A Calvo, C Caponnetto, FL Conforti, M Corbo, ... Journal of Neurology, Neurosurgery & Psychiatry 85 (5), 478-485, 2014 | 162 | 2014 |
| Genetic correlation between amyotrophic lateral sclerosis and schizophrenia RL McLaughlin, D Schijven, W Van Rheenen, KR Van Eijk, M O’brien, ... Nature communications 8 (1), 14774, 2017 | 147 | 2017 |
| Physical activity and amyotrophic lateral sclerosis: A European population‐based case–control study E Pupillo, P Messina, G Giussani, G Logroscino, S Zoccolella, A Chiò, ... Annals of neurology 75 (5), 708-716, 2014 | 140 | 2014 |
| Serum C-reactive protein as a prognostic biomarker in amyotrophic lateral sclerosis C Lunetta, A Lizio, E Maestri, VA Sansone, G Mora, RG Miller, SH Appel, ... JAMA neurology 74 (6), 660-667, 2017 | 133 | 2017 |
| Factors predicting survival in ALS: a multicenter Italian study A Calvo, C Moglia, C Lunetta, K Marinou, N Ticozzi, GD Ferrante, C Scialo, ... Journal of neurology 264, 54-63, 2017 | 127 | 2017 |
| Clinical exome sequencing in early‐onset generalized dystonia and large‐scale resequencing follow‐up M Zech, S Boesch, A Jochim, S Weber, T Meindl, B Schormair, T Wieland, ... Movement Disorders 32 (4), 549-559, 2017 | 126 | 2017 |
| Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) J Mandrioli, R D’Amico, E Zucchi, A Gessani, N Fini, A Fasano, ... Medicine 97 (24), e11119, 2018 | 123 | 2018 |
| Strictly monitored exercise programs reduce motor deterioration in ALS: preliminary results of a randomized controlled trial C Lunetta, A Lizio, VA Sansone, NM Cellotto, E Maestri, M Bettinelli, ... Journal of neurology 263, 52-60, 2016 | 122 | 2016 |
| Structural brain correlates of cognitive and behavioral impairment in MND F Agosta, PM Ferraro, N Riva, EG Spinelli, A Chio, E Canu, P Valsasina, ... Human brain mapping 37 (4), 1614-1626, 2016 | 121 | 2016 |
| Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials RPA van Eijk, AR Jones, W Sproviero, A Shatunov, PJ Shaw, PN Leigh, ... Neurology 89 (18), 1915-1922, 2017 | 116 | 2017 |
| Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial N Riva, G Mora, G Sorarù, C Lunetta, OE Ferraro, Y Falzone, L Leocani, ... The Lancet Neurology 18 (2), 155-164, 2019 | 105 | 2019 |
| Emotional empathy in amyotrophic lateral sclerosis: a behavioural and voxel-based morphometry study C Cerami, A Dodich, N Canessa, C Crespi, S Iannaccone, M Corbo, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15 (1-2), 21-29, 2014 | 105 | 2014 |
